Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$267.54+0.34 (+0.13%)
Delayed quote: Sep 16, 2026, 12:55 PM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 16, 2026, 12:55 PM EDT
Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 10.46% is 12% below its 5-year average of 11.95%, near the low end of its 5-year range (7.81%–20.98%).
1.65% below its 12-month average of 10.63%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-28): 2.75%.
RETURN ON ASSETS (ROA)
10.46%
RETURN ON ASSETS (ROA) AVG TTM
10.63%
RETURN ON ASSETS (ROA) AVG 3Y
12.96%
RETURN ON ASSETS (ROA) AVG 5Y
11.95%
RETURN ON ASSETS (ROA) AVG 10Y
10.49%
RETURN ON ASSETS (ROA) AVG 15Y
10.49%
RETURN ON ASSETS (ROA) AVG 20Y
11.63%
CURRENT VS TTM AVG
-1.65%
CURRENT VS 3Y AVG
-19.26%
CURRENT VS 5Y AVG
-12.47%
CURRENT VS 10Y AVG
-0.28%
CURRENT VS 15Y AVG
-0.33%
CURRENT VS 20Y AVG
-10.05%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+103.50%
vs the sector median at left
Johnson & Johnson
Market Cap
$644.74B
Return on Assets (ROA)
10.46%
TTM Avg
10.63%
3Y Avg
12.96%
5Y Avg
11.95%
Market Cap
$355.81B
Return on Assets (ROA)
2.44%
TTM Avg
13.98%
3Y Avg
10.40%
5Y Avg
10.28%
Market Cap
$465.07B
Return on Assets (ROA)
4.67%
TTM Avg
3.16%
3Y Avg
4.61%
5Y Avg
4.90%
Market Cap
$1.07T
Return on Assets (ROA)
18.77%
TTM Avg
15.90%
3Y Avg
13.15%
5Y Avg
12.89%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Johnson & Johnson (JNJ) | $644.74B | 10.46% | 10.63% | 12.96% | 11.95% |
| Pfizer Inc. (PFE)vs › | $156.79B | 2.16% | 3.75% | 6.08% | 7.08% |
| Merck & Co., Inc. (MRK)vs › | $355.81B | 2.44% | 13.98% | 10.40% | 10.28% |
| AbbVie Inc. (ABBV)vs › | $465.07B | 4.67% | 3.16% | 4.61% | 4.90% |
| Eli Lilly and Company (LLY)vs › | $1.07T | 18.77% | 15.90% | 13.15% | 12.89% |
| Bristol-Myers Squibb Company (BMY)vs › | $130.71B | 10.59% | -0.92% | 3.28% | 1.99% |
ROA
10.5%
ROE
24.8%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-28 | 13.46% |
| 2024-12-29 | 7.81% |
| 2023-12-31 | 20.98% |
| 2023-01-01 | 9.57% |
| 2022-01-02 | 11.47% |
| 2021-01-03 | 8.41% |
| 2019-12-31 | 9.59% |
| 2018-12-31 | 10.00% |
| 2017-12-31 | 0.83% |
| 2016-12-31 | 11.71% |
| 2015-12-31 | 11.55% |
| 2014-12-31 | 12.52% |
| 2013-12-31 | 10.42% |
| 2012-12-31 | 8.94% |
| 2011-12-31 | 8.51% |
| 2010-12-31 | 12.96% |
| 2009-12-31 | 12.95% |
| 2008-12-31 | 15.25% |
| 2007-12-31 | 13.06% |
| 2006-12-31 | 15.67% |
| 2005-12-31 | 17.09% |
| 2004-12-31 | 15.34% |
| 2003-12-31 | 14.91% |
| 2002-12-31 | 16.27% |
| 2001-12-31 | 14.73% |
| 2000-12-31 | 14.46% |
| 1999-12-31 | 14.65% |
| 1998-12-31 | 11.00% |
| 1997-12-31 | 15.40% |
| 1996-12-31 | 14.43% |